Published in Pharma Law Weekly, January 11th, 2005
"Lack of effective treatment for surgically unresectable hepatocellular carcinoma has made this disease dismal. Although, systemic and/or locoregional chemotherapy and chemo-embolization are among the established treatment options, the results of these modalities are still far from being satisfactory. Systemic interferon (IFN) administration is also used for the treatment of this disease, however, it has high toxicity rates," scientists in Turkey report.
"We conducted a pharmacology guided phase I/II study with the aim to explore the effect of hypoxy and interferon...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.